Inhibitory Effects of a Novel μ-Opioid Receptor Nonpeptide Antagonist, UD-030, on Morphine-Induced Conditioned Place Preference

• 資料種別: 記事
• タイトル: Inhibitory Effects of a Novel μ-Opioid Receptor Nonpeptide Antagonist, UD-030, on Morphine-Induced Conditioned Place Preference
• 著者標目: Soichiro Ide; Noriaki Iwase; Kenichi Arai; Masahiro Kojima; Shigeru Ushiyama; Kaori Taniko; Kazutaka Ikeda
• 出版年月日等: 2023-02-08
• 出版年（W3CDTF）: 2023-02-08
• タイトル（掲載誌）: International Journal of Molecular Sciences
• 巻号年月日等（掲載誌）: 24 4
• 掲載巻: 24
• 掲載号: 4
• 掲載ページ: 3351-
• 掲載年月日（W3CDTF）: 2023-02-08
• 出版事項（掲載誌）: MDPI AG
• 件名標目: Morphine; Narcotic Antagonists; Receptors, Opioid, mu; morphine; Opioid-Related Disorders; Article; Naltrexone; Analgesics, Opioid; Mice, Inbred C57BL; Mice; Receptors, Opioid, delta; Humans; Animals; opioid receptor antagonist; addiction; naltrexone; CPP; reward
• 対象利用者: 一般
• 標準番号（その他）: PMID : 36834763
• DOI: 10.3390/ijms24043351; https://doi.org/10.3390/ijms24043351
• 作成日（W3CDTF）: 2023-02-08
• オンライン閲覧公開範囲: インターネット公開
• 著作権情報: https://creativecommons.org/licenses/by/4.0/
• 関連情報（URI）: https://www.mdpi.com/1422-0067/24/4/3351/pdf
• 参照: Inhibitory effects of the selective μ‐opioid receptor antagonist <scp>UD</scp>‐030 on methamphetamine‐induced conditioned place preference; https://cir.nii.ac.jp/crid/1360306906066382464; Effects of the novel selective κ-opioid receptor agonist NP-5497-KA on morphine-induced reward-related behaviors; https://cir.nii.ac.jp/crid/1360865814742374528
• 参照: (−)-Pentazocine Induces Visceral Chemical Antinociception, but not Thermal, Mechanical, or Somatic Chemical Antinociception, in μ-Opioid Receptor Knockout Mice; https://cir.nii.ac.jp/crid/1360004236793990912; Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia; https://cir.nii.ac.jp/crid/1360011145164838912; Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?; https://cir.nii.ac.jp/crid/1360011145777233408; Effects of test conditions on the outcome of place conditioning with morphine and naltrexone in mice; https://cir.nii.ac.jp/crid/1360017284962862592; Naltrexone shortened opioid detoxification with buprenorphine; https://cir.nii.ac.jp/crid/1360017284963389056; Developing a novel treatment for patients with chronic pain and Opioid User Disorder; https://cir.nii.ac.jp/crid/1360017284964275200; Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors; https://cir.nii.ac.jp/crid/1360017287717672832; Increased Attributable Risk Related to a Functional μ-Opioid Receptor Gene Polymorphism in Association with Alcohol Dependence in Central Sweden; https://cir.nii.ac.jp/crid/1360292620839302272; Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review; https://cir.nii.ac.jp/crid/1360298762020094464; Naltrexone for the Management of Alcohol Dependence; https://cir.nii.ac.jp/crid/1360298764622129792; Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy; https://cir.nii.ac.jp/crid/1360574093984731264; Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in μ-opioid receptor knockout mice; https://cir.nii.ac.jp/crid/1360574096478630272; Opiate Aromatic Pharmacophore Structure−Activity Relationships in CTAP Analogues Determined by Topographical Bias, Two-Dimensional NMR, and Biological Activity Assays; https://cir.nii.ac.jp/crid/1360580235500478720; Chemical Interventions for the Opioid Crisis: Key Advances and Remaining Challenges; https://cir.nii.ac.jp/crid/1360580235876036096; Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction; https://cir.nii.ac.jp/crid/1360580240073862144; Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone; https://cir.nii.ac.jp/crid/1360861709531916672; Constitutively Active Mu Opioid Receptors Mediate the Enhanced Conditioned Aversive Effect of Naloxone in Morphine-Dependent Mice; https://cir.nii.ac.jp/crid/1360861709532346624; Genetic susceptibility of opioid receptor genes polymorphism to drug addiction: A candidate-gene association study; https://cir.nii.ac.jp/crid/1360861709533080960; The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study; https://cir.nii.ac.jp/crid/1360861711580311296; Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness; https://cir.nii.ac.jp/crid/1361137045295163904; Design and synthesis of conformationally constrained somatostatin analogs with high potency and specificity for .mu. opioid receptors; https://cir.nii.ac.jp/crid/1361418518445417984; Exploring the opioid system by gene knockout; https://cir.nii.ac.jp/crid/1361981470178515584; Buprenorphine: A Unique Drug with Complex Pharmacology; https://cir.nii.ac.jp/crid/1361981470934248448; Opioid receptor subtypes: fact or artifact?; https://cir.nii.ac.jp/crid/1362825895299198720; Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone; https://cir.nii.ac.jp/crid/1362825896278757376; The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone; https://cir.nii.ac.jp/crid/1363388846335009792; Buprenorphine Antinociception is Abolished, but Naloxone-Sensitive Reward is Retained, in μ-Opioid Receptor Knockout Mice; https://cir.nii.ac.jp/crid/1363951796217235200; Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues; https://cir.nii.ac.jp/crid/1364233268901055360; Methylnaltrexone in the treatment of opioid-induced constipation; https://cir.nii.ac.jp/crid/1370017282468648454; Novel peptidic mu opioid antagonists: Pharmacologic characterization in vitro and in vivo; https://cir.nii.ac.jp/crid/1370017282468648455; Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms; https://cir.nii.ac.jp/crid/1370017282468648459
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Crossref; https://www.crossref.org; 科学研究費助成事業データベース; https://kaken.nii.ac.jp/ja

• 要約等: <jats:p>Although opioids are widely used to treat moderate to severe pain, opioid addiction and the opioid overdose epidemic are becoming more serious...